Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells

French, M.A., Keane, N.M., McKinnon, E.J., Phung, S. and Price, P. (2007) Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells. HIV Medicine, 8 (3). pp. 148-155.

Link to Published Version: http://dx.doi.org/10.1111/j.1468-1293.2007.00445.x
*Subscription may be required

Abstract

Objectives: HIV-infected patients responding to combination antiretroviral therapy (ART) after experiencing severe immunodeficiency may exhibit persistent immune defects and occasionally experience opportunistic infections (OIs) despite increased CD4 T-cell counts. The investigation of immune defects in such patients was examined in this study. Methods: CD4 effector memory T-cell (T em-cell) function [assessed by blood cytomegalovirus (CMV) interferon-γ (IFN-γ) enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) counts] and B-cell dysregulation [assessed by serum immunoglobulin A (IgA) and IgE levels] were examined in 27 patients with increased CD4 T-cell counts after receiving ART for over 2 years. Two of these patients and one other had developed OIs on ART and are described in detail. Results: Serum levels of IgA and IgE were higher than reference intervals (P<0.001) and CMV IFN-γ ELISPOT counts were lower than those in non-HIV-infected controls (P<0.001) in the HIV-infected patients. Low CMV IFN-γ ELISPOT counts were associated with high IgA levels (r = -0.5, P = 0.01, Spearman's correlation test) and segregated with high IgE levels (P = 0.06, Fisher's test). CMV IFN-γ ELISPOT counts and serum IgA and IgE levels did not change significantly over a median time of 35 (range 8-60) months after the first measurement, whereas CD4 T-cell counts increased. All three patients who experienced OIs had repeatedly low CMV IFN-γ ELISPOT counts and increased serum levels of IgA and/or IgE. Conclusion: Low CD4 T em-cell function and B-cell dysregulation are immune defects that may persist independently of changes in the CD4 T-cell count in HIV-1-infected patients responding to ART and are associated with an increased risk of developing an OI.

Item Type: Journal Article
Murdoch Affiliation: School of Chemical and Mathematical Science
Publisher: Blackwell Publishing
Copyright: © 2007 British HIV Association.
URI: http://researchrepository.murdoch.edu.au/id/eprint/9029
Item Control Page Item Control Page